Daniel Cramer
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 5
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Pancreatic and Hepatic Oncology Research 1
- Partner nations
- United States
In The Last Decade
Daniel Cramer
9 papers receiving 10.3k citations
Daniel Cramer's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 2.7k
- Oncology 3.2k
- Immunology 1.7k
- Pulmonary and Respiratory Medicine 2.3k
- Molecular Biology 4.2k
Countries citing papers authored by Daniel Cramer
This map shows the geographic impact of Daniel Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Cramer more than expected).
Fields of papers citing papers by Daniel Cramer
This network shows the impact of papers produced by Daniel Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Cramer. The network helps show where Daniel Cramer may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4331 |
| 2 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 3 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 4 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 5 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images Hit paper breakdown → | 2018 | 761 |
| 6 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 449 |
| 7 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Hit paper breakdown → | 2018 | 372 |
| 8 | 2018 | 227 | |
| 9 | 2018 | 117 |
About Daniel Cramer
Daniel Cramer is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biophysics, having authored 9 papers that have together received 10.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (2 papers), Single-cell and spatial transcriptomics (2 papers), DNA Repair Mechanisms (1 paper), Immunotherapy and Immune Responses (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (3.2k citations), Immunology (1.7k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Molecular Biology (4.2k citations). Daniel Cramer has collaborated with scholars based in United States. Their work appears in journals such as Cell Reports, Immunity and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.